Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluate the Safety and Efficacy of TJO-087
Sponsor: Taejoon Pharmaceutical Co., Ltd.
Summary
This study aims to evaluate the therapeutic efficacy and safety of investigational product compared with placebo in adult patients with dry eye disease. Patients will receive investigational product or placebo for 3 months, and the therapeutic effect will be assessed based on the change in corneal staining score from baseline.
Official title: A Multi-center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Phase Ⅱ Clinical Trial to Evaluate the Safety and Efficacy of TJO-087
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-04-06
Completion Date
2026-12
Last Updated
2026-09-09
Healthy Volunteers
No
Conditions
Interventions
TJO-087
one drop in each eye, twice daily (1 drop of IP, 1 drop of placebo)
TJO-087
one drop in each eye, twice daily (2 dose of IP)
Vehicle (Placebo solution)
one drop in each eye, twice daily (2 dose of placebo)
Locations (1)
Korea University Guro Hospital
Seoul, South Korea